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Prolonged cultivation of human diploid fibroblasts in vitro is associated with a 
toss of proliferative capacity, which has been considered to be a manifestation of 
senescence at the cellular level (1).  Cultures of senescent populations exhibit a 
marked decrease in the percentage of S phase cells. Most of the cells are blocked 
in G0/G2  although some appear to be blocked in G2  (2-5).  In vitro aging is 
associated with increases in cell volume and nuclear area (6) and with a decrease 
in cell locomotion (7,  8).  Martin and co-workers (9) observed changes in cyto- 
skeletal elements (stress fibers) in the cytoplasm of older cells, which more recent 
work has shown to represent an increased organization of microfilaments into 
bundles (10). 
A similar array of alterations in cell structure and function has been described 
for fibroblasts treated with interferons. There is a  progressive increase in the 
cell population  doubling time of interferon-treated cell  populations (1 2,  12), 
which appears to result from a block in or prolongation of G0/G1 or G2 or both 
(13-2 6). Interferon treatment of human fibroblasts also results in an increase in 
cell volume and nuclear area (2 7). The locomotion of interferon-treated cells is 
decreased and there is an increase in the number of actin-containing micro  fila- 
ment bundles (17,  18). 
The possibility has been considered that the reaction pathway underlying the 
phenotypic  changes  observed  during  in  vitro  aging  of fibroblasts  and  after 
interferon  treatment  may  be  a  common  one  (15,  17).  If so,  the  effects  of 
interferon and senescence on the proliferative capacity of cells may be additive, 
i.e., interferon may be expected to cause the same percent increase in doubling 
time at varying population doubling levels.  We have found that the population 
growth rate, modal cell volume, and thymidine uptake are affected to a similar 
extent at middle and high population doubling levels, but that DNA replication 
is affected differently depending on the in vitro age of the cultures. 
Materials and Methods 
Cells and  Culture  Conditions.  The human diploid fibrob[ast cell line 76-109,  kindly 
provided by Dr. George M. Martin, Department of Pathology, University of Washington, 
Seattle, was originally isolated from the foreskin of a 4-d-old newborn (19). The cells were 
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subcultured  once  a  week  using  a  solution  of 0.13%  trypsin  (1-300;  ICN  Nutritional 
Biochemicals, Cleveland, OH)-0.025%  Na~EDTA (trypsin-versene) and seeding at a con- 
centration of 4  ×  10  s cells/cm 2 in Dulbecco-Vogt medium supplemented with  16% fetal 
calf serum  (FCS). 1 The population doubling level (PDL) at each passage was calculated 
from [log(cell number at passage) -  log (cell number seeded)I/log 2. For experimentation, 
cells were seeded at a  density of 1.6  ×  103 cells/cm 2 in tissue culture flasks or culture 
dishes. 
Interferon Treatment.  Two preparations of partially purified human/3 interferon were 
used; one was provided by Dr. J. Horoszewicz, Roswell Park Memorial Institute, Buffalo, 
NY (sp act, 5.2 ×  107 U/mg protein) and the other by Dr. W. Carter, Temple University, 
PA (sp act,  1 ×  107 U/mg protein).  Interferon preparations were titered by the semimi- 
crotitration  procedure  of Havell and  Viff:ek (20)  on monolayers of either  76-109 cells 
(PDL 49) or FS4 cells (passaged as described above but in medium plus 10% FCS). Titers 
are expressed as units/ml  (U/ml) using human fibroblast interferon  reference  standard 
69/19 for comparison. 
Interferon was added directly to cell cultures at a  final concentration of 1,000 U/ml 
24  h  after  seeding.  An  equivalent  amount  of bovine  serum  albumin  (2  #g/ml  final 
concentration) was added to other cultures as a control for the interferon received from 
Dr.  Horoszewicz. Plasmanate at a  final concentration of 2  #g/ml (Cutter  Laboratories, 
Inc., Berkeley, CA) and propylene glycol (at a final concentration of 0.05%) was added as 
a control for the interferon from Dr. W. Carter. The source of interferon had no effect 
on the results of experiments. 
Cell Proliferation.  For measurement of population doubling times, cultures in 25-cm  2 
flasks were photographed at 24-h intervals as previously described (21) and cell numbers 
were determined from projected negatives. Population doubling time was calculated from 
the slope of the linear regression curve of cell number vs. time of treatment over a  72-h 
period. 
Cell  Volume.  At  72  h  after  the  beginning  of interferon  treatment,  cultures  were 
harvested by incubating in trypsin-versene for 2-3 min at 37°C. The trypsin was neutral- 
ized by the addition of FCS and the cells were resuspended in phosphate-buffered saline 
with Ca  +~ and Mg  +~ omitted (PBS def). Cell volume analysis was performed with a Coulter 
channelyzer model ZBI (Coulter Electronics,  Inc., Hialeah,  FL), courtesy of Dr. Arthur 
Balin, as previously described (17).  Volume measurements were calibrated with polysty- 
rene beads of 19.2 ttm diam. 
Thymidine Incorporation into Soluble Pools and DNA.  At varying times after the begin- 
ning of interferon treatment, [3H]thymidine (78 Ci/mmol; New England Nuclear, Boston, 
MA) was added directly to cultures at a final concentration of 2 #Ci/ml for a 30-min pulse 
at 37 °C. Within each experiment,  triplicate 35-ram culture dishes were used. At the end 
of the  labeling  period,  monolayers  were  washed  four  times  with  cold  PBS  def and 
solubilized in  1%  sodium dodecyl sulphate  at  4°C.  The suspension  was mixed  with an 
equal volume of 10%  trichloroacetic acid (TCA) and duplicate  10-#1 aliquots from each 
culture dish were then taken for measurements of total incorporation. TCA-precipitable 
material  was collected onto GF/C filters.  The filters  were washed three times with  5% 
TCA, twice with ethanol, dried, and then counted in a toluene-based scintillant (22). The 
difference  between  total  cell-associated  radioactivity per  sample  and  TCA-precipitable 
radioactivity was  recorded  as  radioactivity  incorporated  into  the  acid-soluble  fraction. 
Uptake  into TCA soluble and  TCA-precipitable  material  is expressed  as cpm per  104 
cells.  Cell number was determined from plating efficiency and cell multiplication over the 
72-h period as measured on separate culture flasks. 
3  Autoradiography of [ H]Thymidine-labeled Cells.  Cells were seeded at a  concentration 
of 1.7 ×  10" per mm  ~ in 60-mm dishes containing four 18-mm diam coverglasses.  72 h 
after interferon treatment,  cells were labeled with [~H]thymidine as described above and 
the coverglasses were fixed in three changes of a solution of (3:1) methanol-glacial acetic 
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acid for 15 rain at 26°C and stained for 20 min in 2% acetoorcein. The coverglasses were 
mounted on slides, dipped in Kodak NTB2 emulsion, and incubated in the dark at -20 °C 
for 2 wk. The slides were developed  in Kodak D19 developer.  Two coverglasses were 
used per variable. Nuclei with ->30 silver grains were considered to be labeled; background 
was 0-6 grains per nucleus. The percent of labeled nuclei was calculated from evaluation 
of 500 cells per variable for each experiment. 
Results 
Population Doubling Times.  Cells at high population doubling levels (PDL 55- 
70)  showed  a  mean  population  doubling time  that  was  twice  as  long as  the 
doubling time of cultures at middle PDL, i.e., 30-40 (Table I). For cells at both 
PDL ranges, interferon treatment resulted in a 40-44%  increase in population 
doubling time. Thus, despite the fact that the high PDL cells were dividing less 
frequently than the younger cells, the two cell populations were equally sensitive 
to the antiproliferative action of interferon. 
Cell  Volume.  With increasing PDL, the cell populations exhibited a  shift to 
larger cell volumes, which was evidenced mainly by skewing of the cell volume 
distributions towards higher values (Fig. 1). This is in agreement with the findings 
of Mitsui and  Schneider (6)  who described an age-dependent increase in  cell 
volume.  Table  II  shows  modal  cell  volumes  of populations  after  3  d  of 
interferon treatment. When the ratios for modal cell volumes, interferon treated 
vs. control, were first calculated for each experiment and then pooled, interferon 
treatment caused a  29.3  _+  11.3%  increase at PDL 30-40 and a  23.7  _+ 6.34% 
increase at PDL 55-70.  The interferon-induced increases in volume of young 
vs. old cells were not significantly different by the t test (P >  0.5). 
Thymidine Uptake and Incorporation into DNA.  Aging of  cultures was associated 
with a 22.3% increase in the uptake of [3H]thymidine into the TCA-soluble pool 
during a  30-min period of labeling and a  42.7% decrease in the incorporation 
of [3H]thymidine into TCA-precipitable material expressed per  104 cells (Table 
IIIA).  To  separate  the  effects on  uptake  of [SH]thymidine into TCA-soluble 
pools  from  the  effects  on  DNA  synthesis,  we  have  calculated  the  ratio  of 
radioactivity in TCA-precipitable material to that in total cell-associated material 
(22).  By this measure, the increase in PDL from 30-40 to 55-70 was associated 
with a 55% decrease in DNA synthesis. 
Interferon  treatment  resulted  in  decreases  in  both  the  uptake  of labeled 
precursor  into  the  TCA-soluble  pool  and  incorporation  into  DNA  (Table 
IIIA).When values for [3H]thymidine labeling of the TCA-soluble material in 
TABLE  I 
Prolongation of Population Doubling Time by Interferon Treatment of 
Fibroblast Cultures at Middle and High PDL * 
PDL  Treatment  Population doubling 
time 
30-40  Control  94.1 ±  1.7 
30-40  Interferon  33.7 :t:  9.0 
55-70  Control  57.0 + 13.1 
55-70  Interferon  82.2 + 21.1 
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FIGURE  l.  Effect of 3 interferon treatment on the cell volume distribution of 76-109 cells at 
PDL 30 and PDL 69.  At 72  h  after the beginning of treatment, electronic volume analysis 
was performed on control (  ) and interferon-treated  (1,000 U/ml) (--) 76-109 cells using a 
Coulter channelyzer model ZBI. 
TABLE  II 
Increases in Cell Volume of Interferon-treated Middle and High PDL 
Fibroblasts* 
PDL  Treatment  Modal volume 
30-40  Control  1,888.3 ±  221.1 
30-40  Interfernn  2,422.2 ±  97.8 
55-70  Control  2,057.6 ±  106.3 
55-70  Interferon  2,536.2 _+  40.2 
* Mean results of three experiments expressed as #m  s ±  standard devia- 
tion. 
interferon-treated relative to control cultures are calculated for each experiment 
and then pooled (Table IIIB), interferon treatment is found to decrease uptake 
of [3H]thymidine into the TCA-soluble pool by 22.0% and 14.8% at middle and 
high  PDL,  respectively.  This  difference in  the interferon  effect on thymidine 
uptake at the two PDL was not significant by the t test (P >  0.5).  At PDL 30- 
40, interferon treatment had no effect on DNA synthesis when calculated as the 
ratios of the TCA-precipitable to total cpm. However, at PDL 55-70, interferon 
treatment was associated with a 23% decrease in this ratio, which was marginally 
significant by the t test (P =  0.029). 
Percent  Labeled  Nuclei.  The  above  results  suggest  that  interferon  inhibits 
DNA  replication  in  high  PDL  fibroblasts,  but  not  in  middle  PDL cells.  This 
difference in interferon sensitivity was confirmed by using whole cell autoradiog- 
raphy to determine the percentage of cells synthesizing DNA during a  30-rain 
labeling period at the end of 72 h  of interferon  treatment  (Table IV). First,  it JASNY,  PFEFFER, AND TAMM 
TABLE III 
A. Effects of  Interferon Treatment on Uptake of [3H]Thymidine into the TCA- 
soluble Pool and Incorporation into DNA in Fibroblasts at Middle and High 
PDL* 
1745 
PDL  Treatment 
[~H]Thymidine uptake and incorporation 
TCA-soluble  TCA-precip- TCA-precipita- 
fraction  s  itable  ble/total 
fraction  s  radioactivity 
cpm  cpra 
30-40  Control  3,029 ± 941  969 ± 350  0.238 ± 0.051 
30-40  Interferon  2,405  ± 602  807 ± 261  0.248  ± 0.049 
55-70  Control  4,398 ± 1,337  556 ± 286  0.107  ± 0.000 
55-70  Interferon  3,725  ± 1,196  375 ± 236  0.084 ± 0.041 
B. [3H]Thymidine Labeling: Interferon~Control* 
PDL  TCA-soluble  fraction  TCA-precipitable/total 
radioactivity 
30-40  0.780 ± 0.126  1.044 ± 0.058 
55-70  0.852 ± 0.128  0.773 ± 0.190 
*  Mean results of six experiments ± standard deviation. 
* Per 104 cells. 
TABLE IV 
Effects of Interferon Treatment on the Percent of Labeled Nuclei in 
Middle and High PDL Cells* 
PDL  Treatment  Percent labeled nuclei 
30-40  Control  32.1 + 2.1 
30-40  Interferon  39.4 ± 0.6 
55-70  Control  14.5 ± 2.2 
55-70  Interferon  9.8 ± 1.7 
* Cells were labeled with [SH]thymidine (78 Ci/mmole, 2 ~Ci/ml) for 30 
min. Mean results of three experiments __. standard deviation. 
should be noted that there was a  55% decrease in the percent of labeled cells in 
high as compared with middle PDL cultures, which corresponds to the decrease 
observed in the ratio of TCA-precipitable to total radioactivity after [3H]thymi- 
dine labeling.  Interferon treatment did not decrease the percent of S phase cells 
in cultures at PDL 30-40, but it caused a 32% decrease in PDL 55-70 fibroblasts 
relative  to  controls.  The  ratio  of percent  labeled  nuclei  in  interferon-treated 
cultures vs. controls was 1.24 _+ 0.06 for cultures at PDL 30-40 and 0.68 +  0.03 
for cultures at  PDL 55-70. The difference between the middle and high PDL 
populations was highly significant by the t test (P <  0.001). In these experiments, 
a cell was scored as labeled if it had _>30 grains per nucleus. Interferon treatment 
of high  PDL cultures did  not increase the percent of nuclei with  10-30 grain 
per nucleus. In addition, the washing and fixation procedure used removed cell- 
associated radioactivity that was not incorporated into DNA (23 and unpublished 
observations). Thus, our results are not an artifact of the grain counting thresh- 
old, a  decrease in the uptake of labeled thymidine, or a  decrease in the specific 1746  CELL  MODULATION  BY  INTERFERON  DURING  IN  VITRO  AGING 
activity of the  labeled DNA.  Rather,  they indicate a  PDL-dependent effect of 
interferon on DNA replication. 
Interferon treatment  of middle PDL cells was consistently associated with an 
increase in the percent of labeled nuclei.  This could be explained by an inter- 
feron-induced prolongation of the S phase. Previous studies in 3T3 cells, as well 
as mouse embryo and human fibroblasts, have indicated that the antiproliferative 
effect is associated with an  increase in the  length  of G0/G1  or G2 phase  (13- 
15).  A prolongation  of the S phase or a block in the S phase has been observed 
after interferon treatment of some transformed cell lines (24-27). In the present 
experiments,  the percent of cells synthesizing DNA was significantly decreased 
in high PDL 70-109 fibroblasts after interferon treatment. 
Discussion 
While  the  aging  of  76-109  cells  in  culture  is  associated  with  increases  in 
population  doubling  time  and  cell  volume,  interferon  treatment  causes  even 
further increases.  In terms of population doubling time and cell volume, sensi- 
tivity to  interferon  is  independent  of the  PDL  of fibroblasts  in  culture.  The 
finding  that  76-109  cells at  high  PDL are  as sensitive  to  the antiproliferative 
action of interferon as cells at low PDL is in agreement with previous observations 
of five human  fibroblast cell lines (28) and  with the findings  that  the antiviral 
action of interferon is not affected by the aging of cell populations in vitro (29). 
Our results also show that interferon treatment decreases the uptake of thymidine 
into  the  acid-soluble  pool  at  both  high  and  low  PDL.  However,  interferon 
treatment  appears  to inhibit  DNA replication  in  high  but not in  middle  PDL 
cells. 
It has been suggested that  interferons act as cellular regulators in a  manner 
analogous  to polypeptide hormones  (30).  Previous investigations  on  hormone 
responsiveness during senescence in vitro have indicated that in the majority of 
cell-hormone systems the sensitivity of cells to stimulation by hormones appears 
to decrease with increasing in vitro age (for reviews see 31 and 32). This decrease 
has been correlated with decreases in the number of insulin receptors on human 
skin fibroblasts (33) and glucocorticoid hormone receptors on WI-38 cells (34- 
36).  It  has  also been  demonstrated  that  senescent  cells bind  less  low density 
lipoprotein, which carries cholesterol to cells, than do young cells (37). Sensitivity 
to epidermal growth factor (EGF) stimulation decreases with cellular age, which 
is correlated with a  decrease in the ability of the EGF receptor to be autophos- 
phorylated at tyrosine residues, but is not associated with changes in the number 
of specific binding sites per unit of surface area or the kinetics of EGF binding 
(38, 39). Our findings have provided no evidence of a decrease in the sensitivity 
of cells to/3 interferon with increasing in vitro age. 
A  marked decrease in the percent of cells synthesizing DNA is characteristic 
of in  vitro senescence (3).  Blocks in G0/G1  and  G2 have been associated with 
aging in vitro (2-5).  Studies demonstrating that entry into S phase in immortal 
cell lines is inhibited by fusion to senescent cells (40, 41) suggest that an inhibitor 
of DNA synthesis accumulates in senescent cells. The pattern of protein synthesis 
is altered  as the  PDL  increases  (42),  but a  specific inhibitor  has  not yet been 
identified.  The  further  decrease  in  the  percent  of cells  synthesizing  DNA, JASNY,  PFEFFER,  AND  TAMM  1747 
observed when high PDL 76-109 cells are treated with interferon, may be related 
to an  increased  intracellular  level  of the  putative  inhibitor in  the  interferon- 
treated  fibroblasts.  Our  data  provide  further  support  for  the  hypothesis that 
there is an overlap in the pathways involved in the establishment of the senescent 
state  and  the  interferon-mediated  antiproliferative  state.  Further  studies  to 
determine the interferon-sensitive step in DNA synthesis in older cells are now 
in progress. 
Summary 
Cellular aging had  no  effect on  the ability of 13  interferon  to  increase  cell 
volume and  population  doubling  time  in  76-109  cells,  a  line  of human  skin 
fibroblasts. However, DNA synthesis in cells at high population doubling levels 
(PDL 55-70)  was inhibited after 72  h  of 13 interferon treatment (1,000  U/ml) 
while no inhibition of DNA synthesis was observed in cells at middle population 
doubling levels (PDL 30-40). 
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